Inventor · Brookline, MA, US

John MacLean

22Patents

7h-index

55Co-inventors

64Inventor score

Filing activity: Jul 20, 2011 → Feb 8, 2019

Most-cited inventions

Patent	Title	Area	Cited by	Status
US9556168B2	N-alkylated indole and indazole compounds as RORgammaT inhibitors and uses thereof	Emerging Cross-Sectional Technologies	16	Active
US9487490B2	3-cyclohexenyl and cyclohexyl substituted indole and indazole compounds as RORgammaT inhibitors and uses thereof	Emerging Cross-Sectional Technologies	15	Active
US9663522B2	3-aminocycloalkyl compounds as RORgammaT inhibitors and uses thereof	Emerging Cross-Sectional Technologies	15	Active
US9663502B2	2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease	Chemistry; Metallurgy	12	Active
US9783511B2	Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of disease	Emerging Cross-Sectional Technologies	9	Active
US9809561B2	Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease	Emerging Cross-Sectional Technologies	8	Active
US9745265B2	4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof	Emerging Cross-Sectional Technologies	8	Active
US10221146B2	Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease	Emerging Cross-Sectional Technologies	6	Active
US9943516B2	Inhibitors of IRAK4 activity	Chemistry; Metallurgy	4	Active
US9969749B2	Inhibitors of IRAK4 activity	Chemistry; Metallurgy	4	Active
US9932350B2	Inhibitors of IRAK4 activity	Chemistry; Metallurgy	4	Active
US9926330B2	Inhibitors of IRAK4 activity	Chemistry; Metallurgy	4	Active
US10221142B2	Substituted pyrazole compounds as RORgammaT inhibitors and uses thereof	Emerging Cross-Sectional Technologies	3	Active
US10196354B2	4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof	Emerging Cross-Sectional Technologies	2	Active
US9382226B2	Aldosterone synthase inhibitors	Chemistry; Metallurgy	2	Active
US10745364B2	Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease	Emerging Cross-Sectional Technologies	0	Active
US9351973B2	Pyrazolopyridyl compounds as aldosterone synthase inhibitors	Chemistry; Metallurgy	0	Active
US9193724B2	Triazolopyridyl compounds as aldosterone synthase inhibitors	Chemistry; Metallurgy	0	Active
US9518055B2	Imidazopyridyl compounds as aldosterone synthase inhibitors	Chemistry; Metallurgy	0	Active
US9173873B2	Imidazopyridyl compounds as aldosterone synthase inhibitors	General	0	Revoked
US9567333B2	Triazolopyridyl compounds as aldosterone synthase inhibitors	Chemistry; Metallurgy	0	Active
US9844553B2	Pyrazolopyridyl compounds as aldosterone synthase inhibitors	Chemistry; Metallurgy	0	Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.